Smith Robert C, Gardiner Joseph C, Lyles Judith S, Sirbu Corina, Dwamena Francesca C, Hodges Annemarie, Collins Clare, Lein Catherine, Given C William, Given Barbara, Goddeeris John
Department of Medicine, Michigan State University, East Lansing, Michigan, USA.
Psychosom Med. 2005 Jan-Feb;67(1):123-9. doi: 10.1097/01.psy.0000149279.10978.3e.
Investigators and clinicians almost always rely on Diagnostic and Statistical Manual of Mental Disorder, 4th edition's (DSM-IV) somatoform disorders (and its derivative diagnoses) to characterize and identify patients with medically unexplained symptoms (MUS). Our objective was to evaluate this use by determining the prevalence of DSM-IV somatoform and nonsomatoform disorders in patients with MUS proven by a gold standard chart review.
In a community-based staff model HMO, we identified subjects for a clinical trial using a systematic and reliable chart rating procedure among high-utilizing MUS patients. Only baseline data are reported here. The World Health Organization Composite International Diagnostic Interview provided full and abridged DSM-IV diagnoses. Patients with full or abridged DSM-IV somatoform diagnoses were labeled "DSM somatoform-positive," whereas those without them were labeled "DSM somatoform-negative."
Two hundred six MUS patients averaged 13.6 visits in the year preceding study, 79.1% were females, and the average age was 47.7 years. We found that 124 patients (60.2%) had a nonsomatoform ("psychiatric") DSM-IV diagnosis of any type; 36 (17.5%) had 2 full nonsomatoform diagnoses, and 41 (19.9%) had >2; 92 (44.7%) had some full anxiety diagnosis and 94 (45.6%) had either full depression or minor depression diagnoses. However, only 9 of 206 (4.4%) had any full DSM-IV somatoform diagnosis, and only 39 (18.9%) had abridged somatization disorder. Thus, 48 (23.3%) were "DSM somatoform-positive" and 158 (76.7%) were "DSM somatoform-negative." The latter exhibited less anxiety, depression, mental dysfunction, and psychosomatic symptoms (all p <.001) and less physical dysfunction (p = .011). Correlates of this DSM somatoform-negative status were female gender (p = .007), less severe mental (p = .007), and physical dysfunction (p = .004), a decreased proportion of MUS (p <.10), and less psychiatric comorbidity (p <.10); c-statistic = 0.77.
We concluded that depression and anxiety characterized MUS patients better than the somatoform disorders. Our data suggested radically revising the somatoform disorders for DSM-V by incorporating a new, very large group of now-overlooked DSM somatoform-negative patients who were typically women with less severe dysfunction.
研究者和临床医生几乎总是依赖《精神疾病诊断与统计手册》第四版(DSM-IV)中的躯体形式障碍(及其衍生诊断)来描述和识别有医学无法解释症状(MUS)的患者。我们的目的是通过金标准图表回顾确定MUS患者中DSM-IV躯体形式和非躯体形式障碍的患病率,以评估这种应用。
在一个基于社区的员工模式健康维护组织(HMO)中,我们通过系统且可靠的图表评分程序,在高使用频率的MUS患者中识别出临床试验的受试者。这里仅报告基线数据。世界卫生组织综合国际诊断访谈提供了完整和简略的DSM-IV诊断。有完整或简略DSM-IV躯体形式诊断的患者被标记为“DSM躯体形式阳性”,而没有这些诊断的患者被标记为“DSM躯体形式阴性”。
206名MUS患者在研究前一年平均就诊13.6次,79.1%为女性,平均年龄为47.7岁。我们发现124名患者(60.2%)有任何类型的非躯体形式(“精神”)DSM-IV诊断;36名(17.5%)有2种完整的非躯体形式诊断,41名(19.9%)有超过2种;92名(44.7%)有某种完整的焦虑诊断,94名(45.6%)有完整的抑郁或轻度抑郁诊断。然而,206名患者中只有9名(4.4%)有任何完整的DSM-IV躯体形式诊断,只有39名(18.9%)有简略的躯体化障碍。因此,48名(23.3%)为“DSM躯体形式阳性”,158名(76.7%)为“DSM躯体形式阴性”。后者表现出较少的焦虑、抑郁、精神功能障碍和心身症状(所有p<.001)以及较少的身体功能障碍(p =.011)。这种DSM躯体形式阴性状态的相关因素包括女性性别(p =.007)、较轻的精神(p =.007)和身体功能障碍(p =.004)、MUS比例降低(p<.10)以及较少的精神共病(p<.10);c统计量 = 0.77。
我们得出结论,抑郁和焦虑比躯体形式障碍更能表征MUS患者。我们的数据表明,通过纳入一大群目前被忽视的DSM躯体形式阴性患者(通常是功能障碍较轻的女性),对DSM-V中的躯体形式障碍进行彻底修订。